vancomycin has been researched along with Leukemia, Myeloid, Acute, M4 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almyroudis, N; Forrest, A; Jarkowski, A; Segal, BH; Sweeney, RP; Tan, W; Wang, ES; Wetzler, M | 1 |
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
2 other study(ies) available for vancomycin and Leukemia, Myeloid, Acute, M4
Article | Year |
---|---|
Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Female; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Models, Biological; Practice Guidelines as Topic; Prospective Studies; Time Factors; Tissue Distribution; Vancomycin | 2012 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |